严重急性呼吸综合征冠状病毒 2 （SARS-CoV-2）感染的诊断和临床管理：北京协和医院的操作建议（V2.0）。
Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0).
机构信息
Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China.
出版信息
Emerg Microbes Infect. 2020 Mar 14;9(1):582-585. doi: 10.1080/22221751.2020.1735265. eCollection 2020.
Abstract
Since December 2019, China has been experiencing an outbreak of a new infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical features include fever, coughing, shortness of breath, and inflammatory lung infiltration. China rapidly listed SARS-CoV-2-related pneumonia as a statutory infectious disease. To standardize the diagnosis and treatment of this new infectious disease, an operational recommendation for the diagnosis and management of SARS-CoV-2 infection is developed by Peking Union Medical College Hospital.
摘要
自 2019 年 12 月以来，中国一直在经历一种由严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）引起的新传染病的爆发。临床特征包括发热、咳嗽、呼吸急促和肺部炎症浸润。中国迅速将 SARS-CoV-2 相关肺炎列为法定传染病。为了规范这种新传染病的诊断和治疗，北京协和医院制定了 SARS-CoV-2 感染诊断和管理的操作建议。
相似文献
1
Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0).
Emerg Microbes Infect. 2020 Mar 14;9(1):582-585. doi: 10.1080/22221751.2020.1735265. eCollection 2020.
2
[Diagnosis and clinical management of 2019 novel coronavirus infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)].
Zhonghua Nei Ke Za Zhi. 2020 Feb 4;59(3):186-188. doi: 10.3760/cma.j.issn.0578-1426.2020.03.003.
3
[Management guidelines for vulnerable workers and persons and SARS-CoV-2 in Catalonian businesses].
Arch Prev Riesgos Labor. 2020 Apr 15;23(2):234-252. doi: 10.12961/aprl.2020.23.02.8.
4
COVID-19: before stopping specific infection prevention and control measures, be sure to exclude the diagnosis.
J Hosp Infect. 2020 Jun;105(2):375-376. doi: 10.1016/j.jhin.2020.04.021. Epub 2020 Apr 25.
5
Coronavirus: remote technology spares Chinese clinicians.
Nature. 2020 May;581(7806):30. doi: 10.1038/d41586-020-01326-4.
6
Clinical characteristics of coronavirus disease 2019 in Gansu province, China.
Ann Palliat Med. 2020 Jul;9(4):1404-1412. doi: 10.21037/apm-20-887. Epub 2020 Jul 13.
7
Guidance for otolaryngology health care workers performing aerosol generating medical procedures during the COVID-19 pandemic.
J Otolaryngol Head Neck Surg. 2020 Jun 3;49(1):36. doi: 10.1186/s40463-020-00429-2.
8
Audio Interview: Preparing for the Spread of Covid-19.
N Engl J Med. 2020 Feb 27;382(9):e18. doi: 10.1056/NEJMe2003319.
9
Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China: cross sectional study.
BMJ. 2020 Jun 10;369:m2195. doi: 10.1136/bmj.m2195.
10
The Coronavirus Pandemic: What Does the Evidence Show?
J Nepal Health Res Counc. 2020 Apr 19;18(1):1-9. doi: 10.33314/jnhrc.v18i1.2596.
引用本文的文献
1
Timing of Dexamethasone Initiation and Its Impact on the Outcome of COVID-19 Patients.
Cureus. 2024 Nov 4;16(11):e72983. doi: 10.7759/cureus.72983. eCollection 2024 Nov.
2
COVID-19 and cardiovascular complications: updates of emergency medicine.
Emerg Crit Care Med. 2023 Sep;3(3):104-114. doi: 10.1097/ec9.0000000000000095. Epub 2023 Jun 1.
3
The Symptom Experience and Functioning of Non-Hospitalized COVID-19 Patients Within the First 20 days.
Clin Nurs Res. 2023 Mar;32(3):608-617. doi: 10.1177/10547738231155729. Epub 2023 Feb 17.
4
Cohort study protocol of the Brazilian collaborative research network on COVID-19: strengthening WHO global data.
BMJ Open. 2022 Nov 2;12(11):e062169. doi: 10.1136/bmjopen-2022-062169.
5
Risk factors, thromboembolic events, and clinical course of New-Onset Atrial Fibrillation among COVID-19 hospitalized patients: A multicenter cross-sectional analysis in Iran.
Health Sci Rep. 2022 Oct 17;5(6):e813. doi: 10.1002/hsr2.813. eCollection 2022 Nov.
6
Longitudinal profiles of plasma gelsolin, cytokines and antibody expression predict COVID-19 severity and hospitalization outcomes.
Front Immunol. 2022 Sep 6;13:1011084. doi: 10.3389/fimmu.2022.1011084. eCollection 2022.
7
A Comparison on Efficiency and Aerosol Generation between "Modified and Conventional Technique of Bracket Bonding".
J Pharm Bioallied Sci. 2022 Jul;14(Suppl 1):S698-S701. doi: 10.4103/jpbs.jpbs_868_21. Epub 2022 Jul 13.
8
A meta-analysis of the diagnostic test accuracy of CT-based radiomics for the prediction of COVID-19 severity.
Radiol Med. 2022 Jul;127(7):754-762. doi: 10.1007/s11547-022-01510-8. Epub 2022 Jun 22.
9
Detection of SARS-CoV-2 in Clinical Samples: Target-specific Analysis of Qualitative Reverse Transcription-Polymerase Chain Reaction(RT-PCR) Diagnostic Kits.
IJID Reg. 2021 Dec;1:163-169. doi: 10.1016/j.ijregi.2021.11.004. Epub 2021 Nov 18.
10
Understanding COVID-19 Situation in Nepal and Implications for SARS-CoV-2 Transmission and Management.
Environ Health Insights. 2022 Jun 7;16:11786302221104348. doi: 10.1177/11786302221104348. eCollection 2022.
本文引用的文献
1
[Characteristics and prognostic value of peripheral blood T lymphocyte subsets in patients with severe influenza].
Zhonghua Nei Ke Za Zhi. 2020 Mar 1;59(3):200-206. doi: 10.3760/cma.j.issn.0578-1426.2020.03.006.
2
Prominent plasmacytosis following intravenous immunoglobulin correlates with clinical improvement in Guillain-Barré syndrome.
PLoS One. 2008 May 7;3(5):e2109. doi: 10.1371/journal.pone.0002109.
3
Rapid loss of both CD4+ and CD8+ T lymphocyte subsets during the acute phase of severe acute respiratory syndrome.
Chin Med J (Engl). 2003 Jul;116(7):985-7.
4
Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases.
Clin Diagn Lab Immunol. 2001 Sep;8(5):859-63. doi: 10.1128/CDLI.8.5.859-863.2001.
Zotero 插件